Analyst Ratings for Upstream Bio (UPB)
UPB Rating Summary
UPB Price Target Summary
- Highest: $75.00 (Piper Sandler)
- Lowest: $35.00 (JPMorgan)
- Average: $48.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$48.50 (+533.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$48.50 (+533.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/19/2025 | Mizuho | Joseph Catanzaro | New Coverage | Outperform (N/A) |
51.00 (N/A) |
29.32 (7.66) |
-73.87% | Details |
| 12/2/2025 | LifeSci Capital | N/A | New Coverage | Outperform (N/A) |
43.00 (N/A) |
28.98 (7.66) |
-73.57% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
